top of page
Profile
Join date: Apr 5, 2024
Posts (8)
May 19, 2025 ∙ 1 min
Ymmunobio Achieves Major Preclinical Milestone with YB-800 ADCs
RIEHEN, Switzerland, April 18, 2025 /PRNewswire/ -- Ymmunobio AG (YB), a Swiss-based global biotech company dedicated to the development...
698
0
Jan 26, 2025 ∙ 1 min
Ymmunobio & Paul-Scherrer Institute win Innosuisse grant to develop radiopharmaceutical with YB-800
We are excited to report that our collaboration with the PSI, supported by an Innosuisse Grant, is kicking off now! Sonne there will be...
113
0
Nov 14, 2024 ∙ 1 min
We are very proud to announce our 3rd place achievement at the Prix Galien USA Awards!
We are honored to be nominated and thrilled to secure 3rd place at this presigious event! Although typically only the winner is...
17
0
selenablackmore9
Editor
Admin
More actions
bottom of page